Answers are grounded in this paper and cite their sources.
Malignant hyperthermia is a rare but potentially fatal condition. We present 2 cases of young patients with coronavirus disease 2019 (COVID-19) requiring intubation for hypoxic respiratory failure who both developed significant hyperthermia post intubation and were suspected to have malignant hyperthermia. However, the 2 patients had different responses to conservative management and dantrolene. These cases highlight the increased challenge imposed by intubation complications when managing patients with COVID-19.
No takes yet. Share an insight, caveat, or question.
Ehteshami‐Afshar et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: